When to Refer to Nephrology Based on eGFR
Refer patients to nephrology when eGFR falls below 30 mL/min/1.73 m² (CKD stages G4-G5), though this threshold should be adjusted based on additional clinical factors including albuminuria severity, rate of kidney function decline, and diagnostic uncertainty. 1, 2
Primary eGFR-Based Referral Threshold
- eGFR <30 mL/min/1.73 m² is the consensus threshold across major guidelines for nephrology referral 1, 3, 4, 2, 4, 5
- This recommendation applies to CKD stages G4-G5 and allows for timely preparation for potential renal replacement therapy 1, 2
- The Canadian Society of Nephrology notes that if eGFR <30 is a stable isolated finding with clear diagnosis, formal ongoing care management may not be necessary—specialist advice alone may suffice 1
Important Caveats to the eGFR <30 Threshold
Do not automatically refer all patients with eGFR <30 if they meet certain criteria 1:
- Very advanced age with short life expectancy
- Stable eGFR with relatively clear diagnosis
- Significant comorbidities indicating death risk exceeds kidney failure risk
Earlier Referral Triggers (eGFR 30-60 mL/min/1.73 m²)
Consider nephrology referral at higher eGFR levels when accompanied by:
Albuminuria-Based Triggers
- ACR ≥300 mg/g (≥30 mg/mmol) or PCR ≥500 mg/g, especially with hematuria 1, 5
- ACR >700 mg/g (>70 mg/mmol) as an isolated finding 5
- The Canadian Society specifically recommends referral for proteinuria >1 g/day (ACR ≥60 mg/mmol or PCR ≥100 mg/mmol) as kidney biopsy and immunosuppressive therapy may be indicated at this level 1
Rapid Progression Indicators
- Sustained eGFR decline >20% after excluding reversible causes 1
- Sustained fall in eGFR >30% in patients initiating hemodynamically active therapies 5
- Abrupt sustained decrease in eGFR >20% with features beyond prerenal azotemia or acute tubular necrosis 1
- ≥2-fold increase in albuminuria in patients with significant baseline albuminuria 5
Diagnostic Uncertainty
- eGFR 45-60 mL/min/1.73 m² with any of the following 3:
Additional Non-eGFR Referral Triggers
Refer regardless of eGFR for 1, 5:
- Resistant hypertension requiring ≥4 antihypertensive agents
- Persistent hyperkalemia or other electrolyte abnormalities
- Recurrent or extensive nephrolithiasis
- Hereditary kidney disease
- Difficult management of CKD complications (anemia, secondary hyperparathyroidism, metabolic bone disease)
Risk-Based Approach for Advanced CKD
The 2024 KDIGO guidelines recommend referral when 5-year risk of requiring kidney replacement therapy exceeds 3-5% using validated risk equations 5. This approach recognizes that many elderly patients with low eGFR have higher mortality risk than kidney failure risk 6.
Monitoring Frequency by eGFR and Albuminuria
The Mayo Clinic/KDIGO grid provides visit frequency guidance 7, 4:
- eGFR 45-59 + ACR <30: Monitor every 6 months, treat in primary care
- eGFR 30-44 + ACR 30-299: Monitor every 3 months, consider referral
- eGFR <30 or ACR ≥300: Refer to nephrology regardless of other category
Common Pitfalls to Avoid
- Don't delay referral in rapidly progressing disease: A sustained 20% eGFR decline warrants prompt evaluation even if absolute eGFR remains >30 1
- Don't ignore significant albuminuria: ACR ≥300 mg/g carries high cardiovascular and kidney failure risk and merits specialist input even with preserved eGFR 1
- Don't over-refer stable elderly patients: Those >80 years with stable eGFR 25-45 rarely progress to kidney failure and may not benefit from nephrology referral 6
- Recognize eGFR limitations: eGFR equations consistently overestimate true kidney function, particularly near clinical thresholds of 45 and 60 mL/min/1.73 m² 8
Impact of eGFR Reporting
Automated eGFR reporting has increased nephrology referrals by approximately 40%, with most additional referrals occurring in older diabetic patients with stage 3 CKD 9. While this led to a small decrease in referral appropriateness (74% to 65%), the absolute number of appropriate referrals increased, representing net clinical benefit 9.